<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab3">
 <label>Table 3</label>
 <caption>
  <p>Laboratory data and imaging findings of patients with COVID-19</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th/>
    <th>All patients
     <break/>(
     <bold>
      <italic>N</italic>
     </bold> = 91)
    </th>
    <th>Local cases
     <break/>(
     <bold>
      <italic>n</italic>
     </bold> = 35)
    </th>
    <th>Imported cases
     <break/>(
     <bold>
      <italic>n</italic>
     </bold> = 56)
    </th>
    <th>
     <bold>
      <italic>P</italic>
     </bold> values
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td colspan="5">
     <bold>Blood routine</bold>
    </td>
   </tr>
   <tr>
    <td> White cell count (× 10
     <sup>9</sup>/L), Mean (
     <italic>SD</italic>)
    </td>
    <td>5.45 (2.42)</td>
    <td>5.57 (1.70)</td>
    <td>5.38 (2.79)</td>
    <td>0.502</td>
   </tr>
   <tr>
    <td>   
     <bold>&gt;</bold> 10.0
    </td>
    <td>5 (5.5%)</td>
    <td>1 (2.9%)</td>
    <td>4 (7.1%)</td>
    <td>0.645</td>
   </tr>
   <tr>
    <td>   &lt; 4.0</td>
    <td>21 (23.1%)</td>
    <td>5 (14.3%)</td>
    <td>16 (28.6%)</td>
    <td>0.116</td>
   </tr>
   <tr>
    <td> Lymphocytes (× 10
     <sup>9</sup>/L), Mean (
     <italic>SD</italic>)
    </td>
    <td>1.26 (0.62)</td>
    <td>1.45 (0.59)</td>
    <td>1.14 (0.61)</td>
    <td>0.022</td>
   </tr>
   <tr>
    <td>   &lt; 1.1</td>
    <td>39 (42.9%)</td>
    <td>8 (22.9%)</td>
    <td>31 (55.4%)</td>
    <td>0.002</td>
   </tr>
   <tr>
    <td> Platelets (×  10
     <sup>9</sup>/L), Mean (
     <italic>SD</italic>)
    </td>
    <td>205.8 (69.9)</td>
    <td>239.7 (68.3)</td>
    <td>184.6 (62.6)</td>
    <td>0.001</td>
   </tr>
   <tr>
    <td>   &lt; 150</td>
    <td>23 (25.3%)</td>
    <td>3 (8.3%)</td>
    <td>20 (35.7%)</td>
    <td>0.005</td>
   </tr>
   <tr>
    <td> Hemoglobin (g/L), Mean (
     <italic>SD</italic>)
    </td>
    <td>133.0 (18.1)</td>
    <td>131.7 (17.7)</td>
    <td>133.8 (18.5)</td>
    <td>0.412</td>
   </tr>
   <tr>
    <td colspan="5">
     <bold>Blood biochemistry</bold>
    </td>
   </tr>
   <tr>
    <td> Alanine aminotransferase (U/L, normal range 3–35), Median (IQR)</td>
    <td>21.3 (14.7–34.8)</td>
    <td>22.0 (15.0–31.0)</td>
    <td>20.7 (13.8–35.4)</td>
    <td>0.427</td>
   </tr>
   <tr>
    <td>  Increased (
     <italic>n</italic>, %)
    </td>
    <td>20 (22.0%)</td>
    <td>6 (17.1%)</td>
    <td>14 (25.0%)</td>
    <td>0.379</td>
   </tr>
   <tr>
    <td> Aspartate aminotransferase (U/L, normal range 3–40), Median (IQR)</td>
    <td>22.0 (17.0–30.1)</td>
    <td>24.0 (20.0–32.0)</td>
    <td>20.0 (15.3–28.0)</td>
    <td>0.170</td>
   </tr>
   <tr>
    <td>  Increased (
     <italic>n</italic>, %)
    </td>
    <td>12 (13.2%)</td>
    <td>4 (11.4%)</td>
    <td>8 (14.3%)</td>
    <td>0.761</td>
   </tr>
   <tr>
    <td> Total bilirubin (μmol/L, normal range 4.0–17.1), Median (IQR)</td>
    <td>9.0 (6.5–13.4)</td>
    <td>9.8 (5.9–13.9)</td>
    <td>8.4 (6.5–11.8)</td>
    <td>0.410</td>
   </tr>
   <tr>
    <td>  Increased (
     <italic>n</italic>, %)
    </td>
    <td>13 (14.3%)</td>
    <td>3 (8.6%)</td>
    <td>10 (17.9%)</td>
    <td>0.218</td>
   </tr>
   <tr>
    <td> Albumin (g/L, normal range 35.0–55.0), Median (IQR)</td>
    <td>42.3 (36.2–47.1)</td>
    <td>46.7 (41.4–49.6)</td>
    <td>39.3 (34.7–44.4)</td>
    <td>0.001</td>
   </tr>
   <tr>
    <td>  Decreased (
     <italic>n</italic>, %)
    </td>
    <td>18 (19.8%)</td>
    <td>4 (11.4%)</td>
    <td>14 (25.0%)</td>
    <td>0.114</td>
   </tr>
   <tr>
    <td> PT (sec), Median (IQR)</td>
    <td>11.3 (10.8–11.8)</td>
    <td>11.3 (10.3–12.4)</td>
    <td>11.4 (10.8–12.5)</td>
    <td>0.407</td>
   </tr>
   <tr>
    <td> Serum creatinine (μmol/L), Median (IQR)</td>
    <td>65.8 (48.0–76.9)</td>
    <td>68.0 (50.9–77.0)</td>
    <td>59.0 (47.0–76.8)</td>
    <td>0.835</td>
   </tr>
   <tr>
    <td> Creatine kinase (U/L), Median (IQR)</td>
    <td>63.0 (46.0–93.6)</td>
    <td>70.0 (46.0–127.0)</td>
    <td>62.0 (45.0–84.0)</td>
    <td>0.013</td>
   </tr>
   <tr>
    <td> C-reaction protein (mg/L), Median (IQR)</td>
    <td>12.3 (2.2–45.1)</td>
    <td>5.3 (1.2–30.5)</td>
    <td>17.0 (3.0–51.3)</td>
    <td>0.022</td>
   </tr>
   <tr>
    <td> Procalcitonin (ng/mL), Median (IQR)</td>
    <td>0.04 (0.02–0.06)</td>
    <td>0.04 (0.02–0.09)</td>
    <td>0.03 (0.01–0.06)</td>
    <td>0.778</td>
   </tr>
   <tr>
    <td colspan="5">
     <bold>Chest CT finding</bold>
    </td>
   </tr>
   <tr>
    <td> Unilateral pneumonia</td>
    <td>16 (17.6%)</td>
    <td>8 (22.9%)</td>
    <td>8 (14.3%)</td>
    <td>0.296</td>
   </tr>
   <tr>
    <td> Bilateral pneumonia</td>
    <td>75 (82.4%)</td>
    <td>27 (77.1%)</td>
    <td>48 (85.7%)</td>
    <td>0.296</td>
   </tr>
   <tr>
    <td> Lung periphery</td>
    <td>79 (86.8%)</td>
    <td>29 (82.9%)</td>
    <td>50 (89.3%)</td>
    <td>0.526</td>
   </tr>
   <tr>
    <td> Ground-glass opacity</td>
    <td>80 (87.9%)</td>
    <td>30 (85.7%)</td>
    <td>50 (89.3%)</td>
    <td>0.743</td>
   </tr>
   <tr>
    <td> Multiple Infiltration</td>
    <td>76 (83.5%)</td>
    <td>26 (74.3%)</td>
    <td>50 (89.3%)</td>
    <td>0.061</td>
   </tr>
   <tr>
    <td> Bilateral lung periphery ground-glass opacity</td>
    <td>70 (76.9%)</td>
    <td>25 (71.4%)</td>
    <td>45 (80.4%)</td>
    <td>0.325</td>
   </tr>
   <tr>
    <td> Nodule</td>
    <td>11 (12.1%)</td>
    <td>2 (5.7%)</td>
    <td>9 (16.1%)</td>
    <td>0.193</td>
   </tr>
   <tr>
    <td> Lung consolidation</td>
    <td>8 (8.8%)</td>
    <td>3 (8.6%)</td>
    <td>5 (8.9%)</td>
    <td>1.000</td>
   </tr>
   <tr>
    <td> Pleural effusion</td>
    <td>2 (2.2%)</td>
    <td>0 (0.0%)</td>
    <td>2 (3.6%)</td>
    <td>0.521</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Data are 
   <italic>n</italic> (%) and mean (SD). 
   <italic>N</italic> is the total number of patients with available data. 
   <italic>P</italic> values for comparing two groups were derived using Fisher’s exact test for categorized variables and the 
   <italic>t</italic>-test for continuous variables
  </p>
  <p>
   <italic>COVID-19</italic> Coronavirus disease-2019; 
   <italic>CT</italic> Computed tomography; 
   <italic>SD</italic> Standard deviation; 
   <italic>IQR</italic> Interquartile range
  </p>
 </table-wrap-foot>
</table-wrap>
